Erectile Dysfunction

Erectile dysfunction (ED) is the inability to achieve an erection or maintain it long enough for sexual intercourse. Some treatments for prostate cancer can cause ED:

Radical prostatectomy, a surgery that removes the prostate gland, the seminal vesicles and part of the urethra, is the most common cause of erectile dysfunction. The severity depends on the procedure's impact on the arteries and nerves that control erections. Most men who receive "nerve-sparing" surgery experience improvement over time (recovery may take a couple of years). Some men never recover the ability to have a spontaneous erection.

Radiation or brachytherapy can damage nerves and blood vessels, causing ED. Many men can achieve an erection with prescription medication.

Hormone treatments lower testosterone levels, which can cause ED and lower libido. Men with prostate cancer should not receive testosterone therapy, since this can encourage the growth of cancerous cells. Ask your doctor about treatment options.



Listen to this Expert Angle webinar with Dr. Elterman for more information:

Sexual Dysfunction

May 29, 2018

This webinar reviews the sexual side effects that may occur after prostate cancer treatment. The risk factors of post-prostatectomy erectile dysfunction, recovery time and the benefits and limitations of available treatments will be described including the use of PDE5 inhibitors, vacuums, injections and other devices.









Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.
More

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground
More

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.
More

Researchers discover common markers of tumour hypoxia across 19 cancer types

Landmark pan-cancer study analyzes mutation signatures of low oxygen in more than 8,000 tumours
More

Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More


Click here for news archive